Continuous improvement of FEV<sub>1</sub> in severe eosinophilic asthmatics on anti‐interleukin‐5 therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Continuous improvement of FEV₁ in severe eosinophilic asthmatics on anti‐interleukin‐5 therapy

Published:2024-04-24 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Michils Alain¹,Makhoul Jean‐Pierre¹,Blekic Nathan¹,Haccuria Amaryllis¹,Perez‐Bogerd Silvia¹,Malinovschi Andreï²,Van Muylem Alain¹^ORCID

Affiliation:

1. Chest Department Erasme University Hospital, Université libre de Bruxelles Brussels Belgium

2. Department of Medical Sciences: Clinical Physiology Uppsala University Uppsala Sweden

Funder

Chiesi Farmaceutici

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.16139

Reference6 articles.

1. A 15‐year follow‐up study of ventilatory function in adults with asthma;Lange P;N Engl J Med,1998

2. Blood eosinophil level and lung function trajectories: cross‐sectional and longitudinal studies in European cohorts;Mogensen I;ERJ Open Res,2020

3. Longitudinal trends in clinical characteristics and lung function of patients with severe asthma under treatment in Brazil;Almeida PC;BMC Pulm Med,2016

4. Global Initiative for AsthmaAvailable from:www.ginasthma.org.

5. Anti‐Interleukin‐5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian severe asthma registry;Graff S;J Allergy Clin Immunol Pract,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP